[HTML][HTML] Durable anti-tumor activity of the multi-targeted inhibitor lenvatinib in patients with advanced or metastatic thymic carcinoma: Preliminary results from a …
S Itoh, M Satouchi, J Sato, Y Okuma, S Niho… - Annals of …, 2019 - Elsevier
Background Thymic carcinoma is a rare malignant disease. Standard treatments have not
been established for patients with advanced or metastatic thymic carcinoma previously …
been established for patients with advanced or metastatic thymic carcinoma previously …
[HTML][HTML] Durable anti-tumor activity of the multi-targeted inhibitor lenvatinib in patients with advanced or metastatic thymic carcinoma: Preliminary results from a …
S Itoh, M Satouchi, J Sato, Y Okuma, S Niho… - Annals of …, 2019 - annalsofoncology.org
Background Thymic carcinoma is a rare malignant disease. Standard treatments have not
been established for patients with advanced or metastatic thymic carcinoma previously …
been established for patients with advanced or metastatic thymic carcinoma previously …